• Kymera Therapeutics, Inc. (NASDAQ:KYMR) Given Average Rating of "Moderate Buy" by Analysts

    Source: Buzz FX / 29 Dec 2024 04:36:13   America/New_York


    Kymera Therapeutics, Inc. (NASDAQ:KYMR) Given Average Rating of "Moderate Buy" by Analysts Written by MarketBeat December 29, 2024 Share Link copied to clipboard. Kymera Therapeutics, Inc. ( NASDAQ:KYMR - Get Free Report ) has been given an
    Read more...
Share on,